Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes

European Journal of Pharmacology

Volumn 650, Issue 1, 2011, Pages 479-485

  Kim, Eun Do ^a   Kim, Eunha ^a   Lee, Jung Han ^a   Hyun, Chang Kee ^a  

^a Handong University   (South Korea)

Author keywords

3T3 L1 adipocyte; Adiponectin; AMPK; Glucose transport; Lipid metabolism; Peptide

Indexed keywords

ACYL COENZYME A DESATURASE 1; ADENYLATE KINASE; ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID SYNTHASE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCYLALANYLGLYCYLVALYLGLYCYLTYROSINE; MESSENGER RNA; PEPTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ADIPOCYTE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GLUCOSE TRANSPORT; LIPID METABOLISM; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TRANSPORT;

3T3-L1 CELLS; ADENYLATE KINASE; ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HEPATOCYTES; HYPOGLYCEMIC AGENTS; INSULIN; LIPID METABOLISM; LIPOGENESIS; MICE; MUSCLE FIBERS, SKELETAL; OLIGOPEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 78649731696     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.006     Document Type: Article

References (38)

1. E. Atherton, and R.C. Sheppard Solid Phase Peptide Synthesis: A Practical Approach 1989 Press, Oxford I.R.L
2. T.P. Ciaraldi, A.P. Kong, N.V. Chu, D.D. Kim, S. Baxi, M. Loviscach, R. Plodkowski, R. Reitz, M. Caulfield, S. Mudaliar, and R.R. Henry Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects Diabetes 51 2002 30 36
3. M.D. Fisher, and S.C. Frost Translocation of GLUT1 does not account for elevated glucose transport in glucose-deprived 3T3-L1 adipocytes J. Biol. Chem. 271 1996 11806 11809
4. S.C. Frost, and M.D. Lane Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes J. Biol. Chem. 260 1985 2646 2652
5. L.G. Fryer, A. Parbu-Patel, and D. Carling The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J. Biol. Chem. 277 2002 25226 25232
6. A. Gokcel, Y. Gumurdulu, H. Karakose, Ertorer E. Melek, N. Tanaci, Tutuncu N. Bascil, and N. Guvener Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity Diabetes Obes. Metab. 4 2002 49 55
7. J. Huang, S.H. Hsia, T. Imamura, I. Usui, and J.M. Olefsky Annexin II is a thiazolidinedione-responsive gene involved in insulin-induced glucose transporter isoform 4 translocation in 3T3-L1 adipocytes Endocrinology 145 2004 1579 1586
8. P. Huypens, E. Quartier, D. Pipeleers, and M. Van de Casteele Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase Eur. J. Pharmacol. 518 2005 90 95
9. C.K. Hyun, I.Y. Kim, and S.C. Frost Soluble fibroin enhances insulin sensitivity and glucose metabolism in 3T3-L1 adipocytes J. Nutr. 134 2004 3257 3263
10. S.E. Kahn, R.L. Hull, and K.M. Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 2006 840 846
11. J.Y. Kim, W.E. Van de, M. Laplante, A. Azzara, M.E. Trujillo, S.M. Hofmann, T. Schraw, J.L. Durand, H. Li, G. Li, L.A. Jelicks, M.F. Mehler, D.Y. Hui, Y. Deshaies, G.I. Shulman, G.J. Schwartz, and P.E. Scherer Obesity-associated improvements in metabolic profile through expansion of adipose tissue J. Clin. Invest. 117 2007 2621 2637
12. E.D. Kim, T. Bayaraa, E.J. Shin, and C.K. Hyun Fibroin-derived peptides stimulate glucose transport in normal and insulin-resistant 3T3-L1 adipocytes Biol. Pharm. Bull. 32 2009 427 433
13. N. Kubota, Y. Terauchi, T. Kubota, H. Kumagai, S. Itoh, H. Satoh, W. Yano, H. Ogata, K. Tokuyama, I. Takamoto, T. Mineyama, M. Ishikawa, M. Moroi, K. Sugi, T. Yamauchi, K. Ueki, K. Tobe, T. Noda, R. Nagai, and T. Kadowaki Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and-independent pathways J. Biol. Chem. 281 2006 8748 8755
14. N.K. LeBrasseur, M. Kelly, T.S. Tsao, S.R. Farmer, A.K. Saha, N.B. Ruderman, and E. Tomas Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues Am. J. Physiol. Endocrinol. Metab. 291 2006 E175 E181
15. J.M. Lenhard, S.A. Kliewer, M.A. Paulik, K.D. Plunket, J.M. Lehmann, and J.E. Weiel Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways Biochem. Pharmacol. 54 1997 801 808
16. C.T. Lim, B. Kola, and M. Korbonits AMPK as a mediator of hormonal signaling J. Mol. Endocrinol. 44 2010 87 97
17. N. Maeda, M. Takahashi, T. Funahashi, S. Kihara, H. Nishizawa, K. Kishida, H. Nagaretani, M. Matsuda, R. Komuro, N. Ouchi, H. Kuriyama, K. Hotta, T. Nakamura, I. Shimomura, and Y. Matsuzawa PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein Diabetes 50 2001 2094 2099
18. N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouch, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi, and Y. Matsuzawa Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 Nat. Med. 8 2002 731 737
19. M. Miyazaki, M.T. Flowers, H. Sampath, K. Chu, C. Otzelberger, X. Liu, and J.M. Ntambi Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis Cell Metab. 6 2007 484 496
20. D.E. Moller New drug targets for type 2 diabetes and the metabolic syndrome Nature 414 2001 821 827
21. J.H. Nahm, and Y.S. Oh A study of pharmacological effect of silk fibroin Agric. Sci. 37 1995 145 157
22. D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, R. Sherwin, and B. Zinman Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy Diabetes Care 32 2009 193 203
23. G. Paolisso, L. Amato, R. Eccellente, A. Gambardella, M.R. Tagliamonte, G. Varricchio, C. Carella, D. Giugliano, and F. D'Onofrio Effect of metformin on food intake in obese subjects Eur. J. Clin. Invest. 28 1998 441 446
24. S.A. Phillips, T.P. Ciaraldi, A.P.S. Kong, R. Bandukwala, V. Aroda, L. Carter, S. Baxi, S.R. Mudaliar, and R.R. Henry Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy Diabetes 52 2003 667 674
25. N. Rasouli, and P.A. Kern Adipocytokines and the metabolic complications of obesity J. Clin. Endocrinol. Metab. 93 2008 S64 S73
26. E.D. Rosen, and B.M. Spiegelman Molecular regulation of adipogenesis Annu. Rev. Cell Dev. Biol. 16 2000 145 171
27. M. Stumvoll, B.J. Goldstein, and T.W. van Haeften Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 2005 1333 1346
28. S.R. Tafuri Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes Endocrinology 137 1996 4706 4712
29. M.J. Thomson, M.G. Williams, and S.C. Frost Development of insulin resistance in 3T3-L1 adipocytes J. Biol. Chem. 272 1997 7759 7764
30. M. Tiikkainen, A.M. Hakkinen, E. Korsheninnikova, T. Nyman, S. Makimattila, and H. Yki-Jarvinen Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes Diabetes 53 2004 2169 2176
31. P. Tontonoz, E. Hu, and B.M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor Cell 79 1994 1147 1156
32. A. Woods, D. Azzout-Marniche, M. Foretz, S.C. Stein, P. Lemarchand, P. Ferré, F. Foufelle, and D. Carling Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase Mol. Cell. Biol. 20 2000 6704 6711
33. T. Yamauchi, J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, K. Eto, Y. Akanuma, P. Froguel, F. Foufelle, P. Ferre, D. Carling, S. Kimura, R. Nagai, B.B. Kahn, and T. Kadowaki Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat. Med. 8 2002 1288 1295
34. J.M. Ye, N. Dzamko, A.J. Hoy, M.A. Iglesias, B. Kemp, and E. Kraegen Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats Diabetes 55 2006 2797 2804
35. W.C. Yeh, Z. Cao, M. Classon, and S.L. McKnight Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins Genes Dev. 9 1995 168 181
36. H. Yki-Jarvinen Thiazolidinediones N. Engl. J. Med. 351 2004 1106 1118
37. B.B. Zhang, G. Zhou, and C. Li AMPK: an emerging drug target for diabetes and the metabolic syndrome Cell Metab. 9 2009 407 416
38. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174